Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Ligand Pharm Cmn (NASDAQ: LGND)

$110.19 USD -$3.31 (-2.92%)
Last Price $110.19
Net Change $-3.31 (-2.92%)
Bid $0
Ask Price $0
Open Price $113.01
Previous Close Price $113.5
High Price $113.21
Low Price $109.63
Number of Trades 1,035
Volume 217,800
Fifty Two Week High $139.79 (2016-08-01)
Fifty Two Week Low $87.5 (2016-11-04)
Average Daily Volume 257,871
Share Outstanding 21,000 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $0.57 (2017-05-09)
2nd Quarter Earnings $1.25 (2017-02-23)
3nd Quarter Earnings $0.62 (2016-11-03)
4th Quarter Earnings $0.5 (2016-08-04)
PE Ratio $257.95
EPS Growth $1986.36
Recent Earnings $0.57
Annual EPS $0.44
Last Quarter EPS $
Market Capitalization $2.31B
Insider Shareholders % 0.147%
Annual Revenue $0B
No. Shares Outstanding 21,000
Inst. Shareholder % 0%
Annual Net Income $-0B
TTM Net Profit Margin $-2.91
1-Year Return -10.28%
3-Year Return 64.81%
5-Year Return 770.38%
5-Year Revenue Growth 262.75%
5-Year Earnings Growth -121.15%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 1986.359985%
Dividends per Share $2.5
Stock Split Ratio 1-6
Beta 1.21
Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.

LGND News & Stock Updates